Summary
Vitamin K2 (menaquinone) acts on the bone metabolism. Menatetrenon (MK -4) is a vitamin K2 homologue that has been used as a therapeutic agent for osteoporosis in Japan. Rat models of immobilization induced by sciatic neurectomy are characterized by transiently increased bone resorption and sustained reduction in bone formation. Using such a rat model, we investigated the efficacy of MK-4 on bone loss. Male Sprague-Dawley rats were subjected to unilateral sciatic neurectomy and administered MK-4 for 28d begin ning day 21 after operation. The effect of MK-4 on the immobilized bone was assessed by measuring the bone mineral density of the femur, breaking force of the femoral diaphysis, and bone histomorphometry in tibial diaphysis. The BMD on both the femoral distal meta physis and diaphysis was reduced by sciatic neurectomy. The administration of MK-4 ame liorated this reduction in a dose-dependent manner. The administration of 30mg/kg MK-4 ameliorated the reduction in bone strength. An improvement in bone formation was observed following the administration of MK-4. These results suggest that MK-4 has a ther apeutic potential for immobilization-induced osteopenia. Vitamin K exists in two forms, vitamin Kl and vita min K2, in nature. Vitamin Kl is contained in seaweed and green plants. Vitamin K2 is contained in cheese, egg yolk, and fermented soybeans (natto), and is also synthesized by bacteria in the bowel. In more recent studies, dietary vitamin K intake was found to be asso ciated with a high incidence of femoral neck and verte bral fractures (1, 2) . Soybeans fermented (natto) by Bacillus natto, a traditional Japanese food, contain 100 times more vitamin K2 (mainly menaquinone-7) than cheese (3). Two reports have suggested that natto con sumption is associated with the frequency of hip frac ture and bone mineral density in Japanese women (4, 5) .
Menatetrenone (MK-4) is a vitamin K2 homologue that has been used as a therapeutic agent for osteoporo sis in Japan. Recent clinical studies have suggested that MK-4 effectively prevents the occurrence of new frac tures in patients with postmenopausal osteoporosis (6 -8) and ameliorates osteoporosis associated with Parkin son's disease (9) . The effects of MK-4 on bone metabo lism were demonstrated in a model of postmenopausal osteoporosis (10) (11) (12) . It is generally accepted that bone resorption is increased in ovariectomized rats. Various studies have suggested that MK-4 prevents, to some extent, the bone loss induced by ovariectomy by inhibit ing bone resorption (10, 11) . We reported that MK-4 protected against the loss of trabecular bone volume and its structure in rats rendered osteoporosic by sciatic neurectomy, through the process of maintaining bone formation (13 Three weeks after neurectomy, six neurectomized rats (SNx) and six sham-operated rats were sacrificed to obtain pre-administration data (day 21). The rest of the neurectomized rats were divided into three groups. SNx rats were administered either 10mg/kg MK-4 (SNx+LK), 30mg/kg MK-4 (SNx+HK), or the vehicle (SNx+vehicle). MK-4 (menatetrenone; Eizai Co. Ltd., Tokyo, Japan) was given as a dietary supplement 30mg/100g, 85mg/100g of the diet, respectively. The dosages of MK-4 were set based on the results of earlier studies (10, 12, 13 Bone mineral densitometry (BMD). At the designed determination points, bone samples were taken and all the connective tissues were carefully removed. BMD was measured by directly applying radiation beams. The BMD of the right femur was determined by dual energy X-ray absorptiometry (DXA) using QDR-1500 (Hologic, Waltham, MA, USA). The ultrahigh resolution scan mode (rat mode, Version 4.59 software, Waltham) was used. The BMD of the distal one-fourth of the femur, including the epimetaphyseal region, and of the middle half of the femur representing the cortical dia physeal region, was measured. The coefficient of varia tion of BMD was 0.95% in the rat mode using the step phantom for small animals.
Bone mechanical properties. The three-point bending test was performed on the femur using an Autograph (AG-2000E, Shimadzu, Kyoto, Japan) according to the instructions provided by the manufacturer. Using a 1.0cm sample, the center of the femur was fractured by applying perpendicular pressure at a speed of 100mm/ min. 
Serum biochemistry
Serum parameters on day 49 are shown in Table 2 . There was no difference in the serum levels of Ca, Pi, or Alp among the main four groups (i.e., sham-operated, SNx+vehicle, SNx+LK and SNx+HK) at any determi nation point. In additional, the serum concentrations of PTH and 1,25(OH)2D3 were similar among the SNx groups (data not shown).
Bone mineral density as assessed by DXA On day 21 after the operation, the BMD of the femo ral distal metaphysis was significantly lower in the SNx rats as compared with that of the sham-operated rats. On day 49, the BMD in the femoral distal metaphysis was significantly higher as compared with the value of day 21 in the MK-4-administered groups, whereas BMD continued to fall in the SNx+vehicle group (Fig, la) . On day 49, there was no difference in cortical bone area As shown in Fig. 2 , the breaking force in the SNx+vehicle group was lower as compared to that of the sham group. In the group administered 30mg/kg of MK-4, the value of this parameter was nearly compara ble to that of the sham-operated group. Bone formation in tibial cortical bone Bone formation parameters are shown in Table 3 .
Mineralized surface, mineral apposition rate, and bone formation rate, parameters of bone formation, were sig nificantly lower in the SNx+vehicle group. MK-4 increased these parameters. In the group administered 30mg/kg of MK-4, these parameters increased to the levels of the sham-operated group.
DISCUSSION
The prevention of bone fracture is a major health problem since fractures seriously affect a patient's qual ity of life. In the present study, we examined the effect of MK-4 on reduced bone mineral density induced by sci atic neurectomy. Immobilization-induced osteopenia is characterized by both a sustained decrease in bone for mation and transient increase in bone resorption, resulting in rapid bone loss (14) . In previous reports , bone loss was observed within the first 10d of immobi lization (14, 15) . Loss of bone mineral density induced by sciatic neurectomy occurred within 3wk after the operation. This observation was suitable for expeditious evaluation of the efficacy of MK-4, an anabolic and antiresorption agent.
After 28d of treatment with 30mg/kg MK-4, BMDs in the femoral distal metaphysis and diaphysis were ameliorated in immobilized rats. The supplementation of 30mg/kg MK-4 also significantly ameliorated the decrease in bone strength at the femoral diaphysis. We previously reported that MK-4 protected against the loss of trabecular bone structure as well as bone volume in rats rendered osteoporotic by sciatic neurectomy (13) . Both the increase in BMD and strength of the fem oral diaphysis indicate that MK-4 may play an effective role in not only cancellous bone, but also in cortical bone. MK-4 inhibits bone resorption in vitro (24-27) and in vivo (10-13) and enhances osteoblast-induced min eralization in vitro (28, 29) . We have previously reported the protective effect of MK-4 on trabecular bone loss induced by sciatic neurectomy (13) . This report suggests that the preventive effect of MK-4 on trabecular bone loss may result in the maintenance of bone formation and increase in bone turnover assessed by bone histomorphometry. In the present study, from the results of bone histomorphometry in the tibial corti cal region (Table 3) , it appeals that MK-4 inhibited the Table 3 .
Effect of MK-4 on bone formation parameters in tibial diaphysis after 28d of treatment. reduction in bone formation induced by immobiliza tion. Treatment commenced from 3wk after the opera tion to avoid any influence of transition and rapid increase in bone resorption caused immediately by unloading (14) . The increase in bone mineral density and strength of the femoral diaphysis may be due to the enhancement of cortical bone formation rather than suppression of bone resorption by MK-4. In conclusion, our findings indicate that MK-4 ame liorates the loss in both femoral cancellous and cortical bone induced by sciatic neurectomy. The increase in BMD of the femur treated by MK-4 may be effective pre vention for bone fracture. Furthermore, these results show that food containing vitamin K2 (MK4 or MK-7) may be a useful tool for high-risk subjects with disuse induced osteopenia.
